Patents Assigned to Aragene, Inc.
  • Lipoproteins as nucleic acid vectors
    Publication number: 20050096288
    Abstract: The present invention relates to a composition and method for activating an antigen specific immune response using by providing a host with a native low density lipoprotein and a nucleic acid that expressed an antigen bound to the low density lipoprotein.
    Type: Application
    Filed: July 20, 2004
    Publication date: May 5, 2005
    Applicant: Aragene, Inc.
    Inventor: Juan Guevara